Paramyotonia Congenita
Symptoms, Doctors, Treatments, Advances & More

Learn About Paramyotonia Congenita

What is the definition of Paramyotonia Congenita?

Paramyotonia congenita is a disorder that affects muscles used for movement (skeletal muscles). Beginning in infancy or early childhood, people with this condition experience bouts of sustained muscle tensing (myotonia) that prevent muscles from relaxing normally. Myotonia causes muscle stiffness that typically appears after exercise and can be induced by muscle cooling. This stiffness chiefly affects muscles in the face, neck, arms, and hands, although it can also affect muscles used for breathing and muscles in the lower body. Unlike many other forms of myotonia, the muscle stiffness associated with paramyotonia congenita tends to worsen with repeated movements.

What are the causes of Paramyotonia Congenita?

Mutations in the SCN4A gene cause paramyotonia congenita. This gene provides instructions for making a protein that is critical for the normal function of skeletal muscle cells. For the body to move normally, skeletal muscles must tense (contract) and relax in a coordinated way. Muscle contractions are triggered by the flow of positively charged atoms (ions), including sodium, into skeletal muscle cells. The SCN4A protein forms channels that control the flow of sodium ions into these cells.

How prevalent is Paramyotonia Congenita?

Paramyotonia congenita is an uncommon disorder; it is estimated to affect fewer than 1 in 100,000 people.

Is Paramyotonia Congenita an inherited disorder?

This condition is inherited in an autosomal dominant pattern, which means one copy of the altered gene in each cell is sufficient to cause the disorder. In many cases, an affected person has one parent with the condition.

Who are the top Paramyotonia Congenita Local Doctors?
Elite in Paramyotonia Congenita
Elite in Paramyotonia Congenita
Referral may be required

Clinical Research Center

4350 Shawnee Mission Parkway, 
Fairway, KS 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Jeffrey Statland is a Neurologist practicing medicine in Fairway, Kansas. Dr. Statland is rated as an Elite provider by MediFind in the treatment of Paramyotonia Congenita. He is also highly rated in 51 other conditions, according to our data. His clinical expertise encompasses Facioscapulohumeral Muscular Dystrophy (FSHD), Paramyotonia Congenita, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Primary Lateral Sclerosis, and Gastrostomy. Dr. Statland is board certified in American Board Of Psychiatry And Neurology, Neurology - 2011. Dr. Statland is currently accepting new patients.

Distinguished in Paramyotonia Congenita
Distinguished in Paramyotonia Congenita
Referral may be required

OSF Illinois Neurological Institute - Neurology

200 East Pennsylvania Avenue, 
Peoria, IL 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Gregory Blume is a Neurologist practicing medicine in Peoria, Illinois. Dr. Blume is rated as a Distinguished provider by MediFind in the treatment of Paramyotonia Congenita. He is also highly rated in 27 other conditions, according to our data. His clinical expertise encompasses Myasthenia Gravis, Paramyotonia Congenita, Myotonic Dystrophy Type 2, and Myotonic Dystrophy. Dr. Blume is board certified in American Board Of Psychiatry And Neurology. Dr. Blume is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Paramyotonia Congenita
Elite in Paramyotonia Congenita
Referral may be required
Milan, IT 

Giovanni Meola practices practicing medicine in Milan, Italy. Mr. Meola is rated as an Elite expert by MediFind in the treatment of Paramyotonia Congenita. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Paramyotonia Congenita, Myotonic Dystrophy, Myotonic Dystrophy Type 2, Myotonia Congenita, and Thymectomy.

What are the latest Paramyotonia Congenita Clinical Trials?
Match to trials
Find the right clinical trials for you in under a minute
Get started
Establishing Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1) Extension

Summary: Myotonic Dystrophy type 1 (DM1) is an autosomal dominant multisystemic disorder that causes progressive disability and shortened life expectancy. It is characterized by progressive weakness and myotonia, which preferentially affects the craniofacial, hand, and distal leg muscles. Many patients also experience difficulties with cognition, cardiac arrhythmias, respiratory failure, or cataracts. Curr...

Who are the sources who wrote this article ?

Published Date: August 01, 2015
Published By: National Institutes of Health